Net Debt Summary of ResMed Inc.

ResMed Inc.'s latest annual net debt in 2024 was 635.57 Million USD , down -52.99% from previous year.
ResMed Inc.'s latest quarterly net debt in 2024 FY was 635.57 Million USD , down -52.99% from previous quarter.
ResMed Inc. reported annual net debt of 1.35 Billion USD in 2023, up 109.99% from previous year.
ResMed Inc. reported annual net debt of 643.84 Million USD in 2022, up 29.17% from previous year.
ResMed Inc. reported quarterly net debt of 1.18 Billion USD for 2024 Q2, down -8.19% from previous quarter.
ResMed Inc. reported quarterly net debt of 635.57 Million USD for 2024 Q4, down -31.62% from previous quarter.

Annual Net Debt Chart of ResMed Inc. (2024 - 1993)

Historical Annual Net Debt of ResMed Inc. (2024 - 1993)

Year	Net Debt	Net Debt Growth
2024	635.57 Million USD	-52.99%
2023	1.35 Billion USD	109.99%
2022	643.84 Million USD	29.17%
2021	498.43 Million USD	-40.39%
2020	836.1 Million USD	-25.6%
2019	1.12 Billion USD	1111.52%
2018	92.75 Million USD	-63.86%
2017	256.67 Million USD	-42.13%
2016	443.56 Million USD	206.46%
2015	-416.65 Million USD	31.12%
2014	-604.94 Million USD	-5.16%
2013	-575.26 Million USD	-2.96%
2012	-558.7 Million USD	12.03%
2011	-635.1 Million USD	-73.01%
2010	-367.08 Million USD	-44.57%
2009	-253.91 Million USD	-38.43%
2008	-183.42 Million USD	-29.36%
2007	-141.79 Million USD	-44.01%
2006	-98.46 Million USD	-405.94%
2005	32.18 Million USD	305.56%
2004	-15.65 Million USD	-1161.64%
2003	-1.24 Million USD	-102.46%
2002	50.39 Million USD	-54.13%
2001	109.86 Million USD	701.99%
2000	-18.25 Million USD	-64.41%
1999	-11.1 Million USD	27.45%
1998	-15.3 Million USD	-80.0%
1997	-8.5 Million USD	-84.78%
1996	-4.6 Million USD	-84.0%
1995	-2.5 Million USD	24.24%
1994	-3.3 Million USD	-135.71%
1993	-1.4 Million USD	0.0%

Year	Net Debt	Net Debt Growth
2024 FY	635.57 Million USD	-52.99%
2024 Q2	1.18 Billion USD	-8.19%
2024 Q4	635.57 Million USD	-31.62%
2024 Q1	1.28 Billion USD	-4.84%
2024 Q3	929.53 Million USD	-21.3%
2023 FY	1.35 Billion USD	109.99%
2023 Q4	1.35 Billion USD	-9.64%
2023 Q2	1.68 Billion USD	133.08%
2023 Q3	1.49 Billion USD	-11.27%
2023 Q1	723.46 Million USD	12.37%
2022 FY	643.84 Million USD	29.17%
2022 Q1	673.95 Million USD	35.21%
2022 Q2	642.38 Million USD	-4.68%
2022 Q3	630.31 Million USD	-1.88%
2022 Q4	643.84 Million USD	2.15%
2021 Q3	638.16 Million USD	-10.11%
2021 Q2	709.94 Million USD	-7.5%
2021 Q1	767.52 Million USD	-8.2%
2021 FY	498.43 Million USD	-40.39%
2021 Q4	498.43 Million USD	-21.9%
2020 Q1	1.13 Billion USD	0.86%
2020 FY	836.1 Million USD	-25.6%
2020 Q3	1.15 Billion USD	-3.42%
2020 Q4	836.1 Million USD	-27.55%
2020 Q2	1.19 Billion USD	5.42%
2019 Q4	1.12 Billion USD	-5.5%
2019 Q1	299.42 Million USD	222.82%
2019 FY	1.12 Billion USD	1111.52%
2019 Q3	1.18 Billion USD	13.47%
2019 Q2	1.04 Billion USD	250.01%
2018 Q2	160.23 Million USD	-22.88%
2018 Q3	105.71 Million USD	-34.02%
2018 Q1	207.76 Million USD	-19.05%
2018 Q4	92.75 Million USD	-12.26%
2018 FY	92.75 Million USD	-63.86%
2017 Q1	391.47 Million USD	-11.74%
2017 Q3	341.04 Million USD	-10.34%
2017 Q4	256.67 Million USD	-24.74%
2017 FY	256.67 Million USD	-42.13%
2017 Q2	380.35 Million USD	-2.84%
2016 Q3	-282.88 Million USD	-9.97%
2016 Q1	-321.46 Million USD	22.85%
2016 Q2	-257.22 Million USD	19.98%
2016 Q4	443.56 Million USD	256.8%
2016 FY	443.56 Million USD	206.46%
2015 Q1	-505.99 Million USD	16.36%
2015 FY	-416.65 Million USD	31.12%
2015 Q3	-405.74 Million USD	5.87%
2015 Q4	-416.65 Million USD	-2.69%
2015 Q2	-431.03 Million USD	14.81%
2014 Q3	-542.76 Million USD	-1.1%
2014 Q2	-536.86 Million USD	12.81%
2014 Q1	-615.76 Million USD	-7.04%
2014 Q4	-604.94 Million USD	-11.46%
2014 FY	-604.94 Million USD	-5.16%
2013 Q3	-671.88 Million USD	-2.2%
2013 Q4	-575.26 Million USD	14.38%
2013 FY	-575.26 Million USD	-2.96%
2013 Q2	-657.42 Million USD	-5.22%
2013 Q1	-624.79 Million USD	-11.83%
2012 Q3	-540.08 Million USD	-8.72%
2012 Q2	-496.78 Million USD	-4.37%
2012 Q1	-475.96 Million USD	25.06%
2012 Q4	-558.7 Million USD	-3.45%
2012 FY	-558.7 Million USD	12.03%
2011 FY	-635.1 Million USD	-73.01%
2011 Q4	-635.1 Million USD	-7.38%
2011 Q3	-591.46 Million USD	-7.18%
2011 Q2	-551.84 Million USD	-23.68%
2011 Q1	-446.2 Million USD	-21.55%
2010 Q1	-314.43 Million USD	-23.84%
2010 FY	-367.08 Million USD	-44.57%
2010 Q2	-306.3 Million USD	2.58%
2010 Q4	-367.08 Million USD	2.69%
2010 Q3	-377.23 Million USD	-23.16%
2009 Q3	-167.49 Million USD	0.05%
2009 Q1	-156.94 Million USD	14.43%
2009 Q2	-167.58 Million USD	-6.78%
2009 FY	-253.91 Million USD	-38.43%
2009 Q4	-253.91 Million USD	-51.6%
2008 Q2	-145.87 Million USD	-7.74%
2008 Q1	-135.39 Million USD	4.51%
2008 Q4	-183.42 Million USD	-4.64%
2008 Q3	-175.28 Million USD	-20.16%
2008 FY	-183.42 Million USD	-29.36%
2007 Q1	-80.84 Million USD	17.89%
2007 Q3	-125.53 Million USD	-26.65%
2007 FY	-141.79 Million USD	-44.01%
2007 Q4	-141.79 Million USD	-12.95%
2007 Q2	-99.12 Million USD	-22.6%
2006 Q4	-98.46 Million USD	-41.29%
2006 FY	-98.46 Million USD	-405.94%
2006 Q3	-69.68 Million USD	-210.09%
2006 Q2	63.29 Million USD	15.57%
2006 Q1	54.77 Million USD	70.18%
2005 Q4	32.18 Million USD	237.25%
2005 Q1	-28.37 Million USD	-81.2%
2005 FY	32.18 Million USD	305.56%
2005 Q2	-29.81 Million USD	-5.1%
2005 Q3	-23.45 Million USD	21.36%
2004 FY	-15.65 Million USD	-1161.64%
2004 Q4	-15.65 Million USD	-1087.94%
2004 Q3	-1.31 Million USD	-115.75%
2004 Q2	8.36 Million USD	-2.4%
2004 Q1	8.57 Million USD	790.81%
2003 FY	-1.24 Million USD	-102.46%
2003 Q4	-1.24 Million USD	-106.35%
2003 Q3	19.53 Million USD	-36.54%
2003 Q2	30.78 Million USD	-31.11%
2003 Q1	44.68 Million USD	-11.33%
2002 Q3	89.77 Million USD	-22.58%
2002 FY	50.39 Million USD	-54.13%
2002 Q1	119.55 Million USD	8.82%
2002 Q2	115.95 Million USD	-3.01%
2002 Q4	50.39 Million USD	-43.87%
2001 Q3	50.85 Million USD	511.56%
2001 FY	109.86 Million USD	701.99%
2001 Q2	-12.35 Million USD	-86.66%
2001 Q1	-6.62 Million USD	63.73%
2001 Q4	109.86 Million USD	116.03%
2000 Q2	-11.5 Million USD	-6.48%
2000 Q4	-18.25 Million USD	-11.58%
2000 Q1	-10.8 Million USD	2.7%
2000 Q3	-16.35 Million USD	-42.23%
2000 FY	-18.25 Million USD	-64.41%
1999 Q2	-13.5 Million USD	17.18%
1999 Q1	-16.3 Million USD	-6.54%
1999 Q4	-11.1 Million USD	-3.74%
1999 FY	-11.1 Million USD	27.45%
1999 Q3	-10.7 Million USD	20.74%
1998 Q4	-15.3 Million USD	-33.04%
1998 FY	-15.3 Million USD	-80.0%
1998 Q1	-12.8 Million USD	-50.59%
1998 Q2	-7.2 Million USD	43.75%
1998 Q3	-11.5 Million USD	-59.72%
1997 Q1	-5.6 Million USD	-21.74%
1997 FY	-8.5 Million USD	-84.78%
1997 Q3	-7.9 Million USD	0.0%
1997 Q2	-7.9 Million USD	-41.07%
1997 Q4	-8.5 Million USD	-7.59%
1996 Q3	-3.1 Million USD	0.0%
1996 Q4	-4.6 Million USD	-48.39%
1996 FY	-4.6 Million USD	-84.0%
1995 FY	-2.5 Million USD	24.24%
1995 Q4	-2.5 Million USD	0.0%
1994 Q4	-3.3 Million USD	0.0%
1994 FY	-3.3 Million USD	-135.71%
1993 FY	-1.4 Million USD	0.0%
1993 Q4	-1.4 Million USD	0.0%

Peer Net Debt Comparison of ResMed Inc.

Name	Net Debt	Net Debt Difference
Alcon Inc.	4.04 Billion USD	84.305%
AptarGroup, Inc.	961.03 Million USD	33.865%
Baxter International Inc.	11.16 Billion USD	94.308%
Becton, Dickinson and Company	14.46 Billion USD	95.606%
Bausch + Lomb Corporation	4.23 Billion USD	84.978%
Haemonetics Corporation	695.08 Million USD	8.562%
Envista Holdings Corp	713.6 Million USD	10.934%
Teleflex Incorporated	1.7 Billion USD	62.691%
Warby Parker Inc.	-42.43 Million USD	1597.688%
West Pharmaceutical Services, Inc.	-544.9 Million USD	216.64%

Global Stocks Search

ResMed Inc. (RMD)

Net Debt Summary of ResMed Inc.

Annual Net Debt Chart of ResMed Inc. (2024 - 1993)

Historical Annual Net Debt of ResMed Inc. (2024 - 1993)

Peer Net Debt Comparison of ResMed Inc.